Medicinova Stock Net Asset
| MNOV Stock | USD 1.43 0.10 7.52% |
Fundamental analysis of MediciNova allows traders to better anticipate movements in MediciNova's stock price by examining its financial health and performance throughout various phases of its business cycle.
MediciNova | Build AI portfolio with MediciNova Stock |
MediciNova Company Net Asset Analysis
MediciNova's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current MediciNova Net Asset | 55.88 M |
Most of MediciNova's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MediciNova is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, MediciNova has a Net Asset of 55.88 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
MediciNova Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MediciNova's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MediciNova could also be used in its relative valuation, which is a method of valuing MediciNova by comparing valuation metrics of similar companies.MediciNova is currently under evaluation in net asset category among its peers.
MediciNova Fundamentals
| Return On Equity | -0.2 | ||||
| Return On Asset | -0.14 | ||||
| Current Valuation | 27.87 M | ||||
| Shares Outstanding | 49.05 M | ||||
| Shares Owned By Insiders | 2.98 % | ||||
| Shares Owned By Institutions | 21.88 % | ||||
| Number Of Shares Shorted | 124.64 K | ||||
| Price To Earning | (24.69) X | ||||
| Price To Book | 1.29 X | ||||
| Price To Sales | 82.89 X | ||||
| EBITDA | (11.02 M) | ||||
| Net Income | (11.05 M) | ||||
| Cash And Equivalents | 65.23 M | ||||
| Cash Per Share | 1.33 X | ||||
| Total Debt | 193.77 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 17.17 X | ||||
| Book Value Per Share | 1.02 X | ||||
| Cash Flow From Operations | (10.64 M) | ||||
| Short Ratio | 5.98 X | ||||
| Earnings Per Share | (0.23) X | ||||
| Price To Earnings To Growth | (0.94) X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 13 | ||||
| Beta | 0.4 | ||||
| Market Capitalization | 64.99 M | ||||
| Total Asset | 55.88 M | ||||
| Retained Earnings | (426.75 M) | ||||
| Working Capital | 38.12 M | ||||
| Current Asset | 22.73 M | ||||
| Current Liabilities | 1.49 M | ||||
| Net Asset | 55.88 M |
About MediciNova Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MediciNova's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MediciNova using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MediciNova based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MediciNova Stock Analysis
When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.